ProfileGDS5822 / ILMN_2772747
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 43% 7% 11% 6% 47% 35% 59% 22% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 119.343
GSM1276600PDAC Late Ablation Control 210.97
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 19.111
GSM1276603PDAC Late Ablation 26.76
GSM1276604PDAC Late Ablation 322.747
GSM1303940PDAC Late Ablation_anti-CTLA4 11735
GSM1303941PDAC Late Ablation_anti-CTLA4 234.959
GSM1303942PDAC Late Ablation_anti-CTLA4 311.422